Prospective, randomized, controlled study of in vitro fertilization-embryo transfer with a single dose of a luteinizing hormone-releasing hormone (LH-RH) antagonist (cetrorelix) or a depot formula of an LH-RH agonist (triptorelin). (Q48898305)

From Wikidata

Jump to navigation Jump to search

scientific article published in February 2000

Language	Label	Description	Also known as
English	Prospective, randomized, controlled study of in vitro fertilization-embryo transfer with a single dose of a luteinizing hormone-releasing hormone (LH-RH) antagonist (cetrorelix) or a depot formula of an LH-RH agonist (triptorelin).	scientific article published in February 2000

Statements

scholarly article

1 reference

Europe PubMed Central

16 February 2018

http://europepmc.org/abstract/MED/10685535

Prospective, randomized, controlled study of in vitro fertilization-embryo transfer with a single dose of a luteinizing hormone-releasing hormone (LH-RH) antagonist (cetrorelix) or a depot formula of an LH-RH agonist (triptorelin). (English)

1 reference

Europe PubMed Central

16 February 2018

http://europepmc.org/abstract/MED/10685535

author name string

F Olivennes

1

1 reference

Europe PubMed Central

16 February 2018

http://europepmc.org/abstract/MED/10685535

J Belaisch-Allart

2

1 reference

Europe PubMed Central

16 February 2018

http://europepmc.org/abstract/MED/10685535

J C Emperaire

3

1 reference

Europe PubMed Central

16 February 2018

http://europepmc.org/abstract/MED/10685535

H Dechaud

4

1 reference

Europe PubMed Central

16 February 2018

http://europepmc.org/abstract/MED/10685535

S Alvarez

5

1 reference

Europe PubMed Central

16 February 2018

http://europepmc.org/abstract/MED/10685535

L Moreau

6

1 reference

Europe PubMed Central

16 February 2018

http://europepmc.org/abstract/MED/10685535

B Nicollet

7

1 reference

Europe PubMed Central

16 February 2018

http://europepmc.org/abstract/MED/10685535

J R Zorn

8

1 reference

Europe PubMed Central

16 February 2018

http://europepmc.org/abstract/MED/10685535

P Bouchard

9

1 reference

Europe PubMed Central

16 February 2018

http://europepmc.org/abstract/MED/10685535

R Frydman

10

1 reference

Europe PubMed Central

16 February 2018

http://europepmc.org/abstract/MED/10685535

language of work or name

0 references

publication date

1 February 2000

1 reference

Europe PubMed Central

16 February 2018

http://europepmc.org/abstract/MED/10685535

Fertility and Sterility

1 reference

Europe PubMed Central

16 February 2018

http://europepmc.org/abstract/MED/10685535

73

1 reference

Europe PubMed Central

16 February 2018

http://europepmc.org/abstract/MED/10685535

2

1 reference

Europe PubMed Central

16 February 2018

http://europepmc.org/abstract/MED/10685535

314-320

1 reference

Europe PubMed Central

16 February 2018

http://europepmc.org/abstract/MED/10685535

The control of endogenous secretion of LH by gonadotrophin-releasing hormone agonists during ovarian hyperstimulation for in-vitro fertilization and embryo transfer

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2899%2900524-5

7 January 2021

The use of gonadotrophin releasing hormone agonists for in vitro fertilization and other assisted procreation techniques: experience from three centres

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2899%2900524-5

7 January 2021

Improved pregnancy outcome with gonadotropin releasing hormone agonist (GnRH-a) stimulation is due to the improvement in oocyte quantity rather than quality

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2899%2900524-5

7 January 2021

Ovarian hyporesponsiveness in combined gonadotropin-releasing hormone agonist and menotropin therapy is associated with low serum follicle-stimulating hormone levels

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2899%2900524-5

7 January 2021

Ovarian hyperstimulation syndrome after superovulation using GnRH agonists for IVF and related procedures

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2899%2900524-5

7 January 2021

Control of the preovulatory Luteinizing Hormone surge by Gonadotropin-Releasing Hormone antagonists: prospects for clinical application

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2899%2900524-5

7 January 2021

A single injection of a gonadotropin-releasing hormone (GnRH) antagonist (Cetrorelix) postpones the luteinizing hormone (LH) surge: further evidence for the role of GnRH during the LH surge

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2899%2900524-5

7 January 2021

Suppression of the endogenous luteinizing hormone surge by the gonadotrophin-releasing hormone antagonist Cetrorelix during ovarian stimulation.

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2899%2900524-5

7 January 2021

Comparison of different doses of gonadotropin-releasing hormone antagonist Cetrorelix during controlled ovarian hyperstimulation

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2899%2900524-5

7 January 2021

Prevention of premature luteinizing hormone and progesterone rise with a gonadotropin-releasing hormone antagonist, Nal-Glu, in controlled ovarian hyperstimulation

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2899%2900524-5

7 January 2021

Spontaneous luteinizing hormone surges can be reliably prevented by the timely administration of a gonadotrophin releasing hormone antagonist (Nal-Glu) during the late follicular phase

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2899%2900524-5

7 January 2021

The single or dual administration of the gonadotropin-releasing hormone antagonist Cetrorelix in an in vitro fertilization-embryo transfer program.

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2899%2900524-5

7 January 2021

The use of a GnRH antagonist (Cetrorelix) in a single dose protocol in IVF-embryo transfer: a dose finding study of 3 versus 2 mg

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2899%2900524-5

7 January 2021

Synchronization of ovarian follicular waves with a gonadotropin-releasing hormone agonist to increase the precision of estrus in cattle: a review

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2899%2900524-5

7 January 2021

Gene expression of gonadotropin-releasing hormone, but not its receptor, in human endometrium and decidua

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2899%2900524-5

7 January 2021

Quantitative gonadotropin-releasing hormone gene expression and immunohistochemical localization in human endometrium throughout the menstrual cycle

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2899%2900524-5

7 January 2021

Possible direct effect of gonadotropin releasing hormone on human endometrium and decidua

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2899%2900524-5

7 January 2021

Identifiers

10.1016/S0015-0282(99)00524-5

1 reference

Europe PubMed Central

16 February 2018

http://europepmc.org/abstract/MED/10685535

1 reference

Europe PubMed Central

16 February 2018

http://europepmc.org/abstract/MED/10685535

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q48898305&oldid=1612304210"